Peer-reviewed veterinary case report
Factors affecting 1-week survival in dogs with unknown cause brain
By Cornelis, I et al.·Published in Veterinary journal (London, England : 1997)·2016·The Royal Veterinary College, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Prognostic factors for 1-week survival in dogs diagnosed with meningoencephalitis of unknown aetiology.
- Species:
- dog
Plain-English summary
A group of dogs diagnosed with meningoencephalitis of unknown cause (MUA) showed concerning short-term survival rates, with 30 out of 116 dogs (about 26%) dying within a week of diagnosis. Key factors linked to a poor outcome included decreased awareness when they were first seen, having seizures, and specific changes in their cerebrospinal fluid. Despite receiving treatment, many dogs did not survive the initial week, highlighting the seriousness of this condition. This information can help veterinarians give pet owners a clearer idea of what to expect if their dog is diagnosed with MUA.
People also search for: dog meningoencephalitis symptoms · dog seizures treatment · prognosis for dogs with meningoencephalitis
Abstract
Although long-term outcomes of meningoencephalitis of unknown aetiology (MUA) in dogs have been evaluated, little is known about short-term survival and initial response to therapy. The aim of this study was to evaluate possible prognostic factors for 7-day survival after diagnosis of MUA in dogs. Medical records were reviewed for dogs diagnosed with MUA between 2006 and 2015. Previously described inclusion criteria were used, as well as 7-day survival data for all dogs. A poor outcome was defined as death within 1 week. Of 116 dogs that met inclusion criteria, 30 (26%) died within 7 days of diagnosis. Assessed variables included age, sex, bodyweight, duration of clinical signs and treatment prior to diagnosis, venous blood glucose and lactate levels, white blood cell count on complete blood count, total nucleated cell count/total protein concentration/white blood cell differentiation on cerebrospinal fluid (CSF) analysis, presence of seizures and cluster seizures, mentation at presentation, neuroanatomical localisation, imaging findings and treatment after diagnosis. Multivariate analysis identified three variables significantly associated with poor outcome; decreased mentation at presentation, presence of seizures, and increased percentage of neutrophils on CSF analysis. Despite initiation of appropriate treatment, more than a quarter of dogs died within 1 week of diagnosis of MUA, emphasising the need for evaluation of short-term prognostic factors. Information from this study could aid clinical staff to provide owners of affected dogs with prognostic information.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/27387733/